Research Articles - QUALIblood

Bayart, J. L. et al.

Waning of IgG, Total and Neutralizing Antibodies 6 Months Post-Vaccination with BNT162b2 in Healthcare Workers.

Vaccines (Basel) 9, 1092 (2021).

Douxfils, J. et al.

Validation and standardization of the ETP-based activated protein C resistance test for the clinical investigation of steroid contraceptives in women: an unmet clinical and regulatory need.

Clinical chemistry and laboratory medicine : CCLM / FESCC 58, 294-305 (2020).

Favresse, J. et al.

Vaccine-induced binding and neutralizing antibodies against Omicron 6 months after a homologous BNT162b2 booster.

J Med Virol 95, e28164 (2023).

Tre-Hardy, M. et al.

The role of serology for COVID-19 control: Population, kinetics and test performance do matter.

J Infect 81, e91-e92 (2020).

Favresse, J. et al.

Unexpected kinetics of anti-SARS-CoV-2 total antibodies in two patients with chronic lymphocytic leukemia.

British journal of haematology 190, e187-e189 (2020).

Hardy, M. et al.

Studies on hemostasis in COVID-19 deserve careful reporting of the laboratory methods, their significance, and their limitations.

Journal of thrombosis and haemostasis : JTH 18, 3121-3124 (2020).

Hardy, M. et al.

Study of in vitro thrombin generation after neutralization of heparin.

International journal of laboratory hematology 44, 168-176 (2022).

Favresse, J. et al.

Spike vs. nucleocapsid serum antigens for COVID-19 diagnosis and severity assessment.

Clinical chemistry and laboratory medicine : CCLM / FESCC 60, e97-e100 (2022).

Favresse, J. et al.

Serum SARS-CoV-2 Antigens for the Determination of COVID-19 Severity

Cold Spring Harbor Laboratory, 2021

Favresse, J. et al.

Response of anti-SARS-CoV-2 total antibodies to nucleocapsid antigen in COVID-19 patients: a longitudinal study.

Clinical chemistry and laboratory medicine : CCLM / FESCC 58, e193-e196 (2020).

Gillot, C. et al.

Resistance towards ChadOx1 nCoV-19 in an 83 Years Old Woman Experiencing Vaccine Induced Thrombosis with Thrombocytopenia Syndrome.

Vaccines (Basel) 10, 2056 (2022).

Hardy, M. et al.

Prothrombotic disturbances of hemostasis of patients with severe COVID-19: A prospective longitudinal observational study.

Thrombosis research 197, 20-23 (2021).

Hardy, M. et al.

Prothrombotic hemostasis disturbances in patients with severe COVID-19: Individual daily data.

Data Brief 33, 106519 (2020).

Favresse, J. et al.

Persistence of Anti-SARS-CoV-2 Antibodies Depends on the Analytical Kit: A Report for Up to 10 Months after Infection.

Microorganisms 9, 556 (2021).

Douxfils, J., Gillot, C., Mullier, F. & Favresse, J.

Post-SARS-CoV-2 vaccination specific antibody decrease – Thresholds for determining seroprevalence and seroneutralization differ.

J Infect 83, e4-e5 (2021).

Gillot, C. et al.

Peri-infection titers of neutralizing and binding antibodies as a predictor of COVID-19 breakthrough infections in vaccinated healthcare professionals: importance of the timing.

Clinical chemistry and laboratory medicine : CCLM / FESCC (2023).

Favresse, J., Bayart, J. L., David, C., Dogne, J. M. & Douxfils, J.

Nucleocapsid serum antigen determination in SARS-CoV-2 infected patients using the single molecule array technology and prediction of disease severity.

J Infect 84, e4-e6 (2022).

Gillot, C. et al.

NETosis and the Immune System in COVID-19: Mechanisms and Potential Treatments.

Frontiers in pharmacology 12, 708302 (2021).

Favresse, J. et al.

Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2.

Viruses 13, 1364 (2021).

Hardy, M. et al.

Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory.

Thrombosis journal 18, 17 (2020).

Morimont, L. et al.

NETosis and Nucleosome Biomarkers in Septic Shock and Critical COVID-19 Patients: An Observational Study.

Biomolecules 12 (2022).

Catry, E. et al.

Lung Transplant Recipients Immunogenicity after Heterologous ChAdOx1 nCoV-19-BNT162b2 mRNA Vaccination.

Viruses 14 (2022).

Favresse, J. et al.

Long-term kinetics of anti-SARS-CoV-2 antibodies in a cohort of 197 hospitalized and non-hospitalized COVID-19 patients.

Clinical chemistry and laboratory medicine : CCLM / FESCC 59, e179-e183 (2021).

Simon, G. et al.

Kinetics and ability of binding antibody and surrogate virus neutralization tests to predict neutralizing antibodies against the SARS-CoV-2 Omicron variant following BNT162b2 booster administration.

Clinical chemistry and laboratory medicine : CCLM / FESCC (2023).

Didembourg, M. et al.

Influence of C-reactive protein on thrombin generation assay.

Clinical chemistry and laboratory medicine : CCLM / FESCC 59, e301-e305 (2021).

Favresse, J. & Douxfils, J.

Importance of sample dilution in the evaluation of the antibody response after SARS-CoV-2 vaccination.

J Infect 84, 94-118 (2022).

Dechamps, M. et al.

Inflammation-induced coagulopathy substantially differs between COVID-19 and septic shock: a prospective observational study.

Frontiers in Medicine (2021).

Gillot, C., Favresse, J., Maloteau, V., Dogne, J. M. & Douxfils, J.

Identification of SARS-CoV-2 Neutralizing Antibody with Pseudotyped Virus-based Test on HEK-293T hACE2 Cells.

Bio Protoc 12, e4377 (2022).

Douxfils, J. et al.

Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination.

Thrombosis research 203, 163-171 (2021).

Mairesse, A. et al.

High clinical performance and quantitative assessment of antibody kinetics using a dual recognition assay for the detection of SARS-CoV-2 IgM and IgG antibodies.

Clin Biochem 86, 23-27 (2020).

Favresse, J. et al.

Head-to-Head Comparison of Rapid and Automated Antigen Detection Tests for the Diagnosis of SARS-CoV-2 Infection.

J Clin Med 10 (2021).

Douxfils, J. et al.

Fatal exacerbation of ChadOx1-nCoV-19-induced thrombotic thrombocytopenia syndrome after initial successful therapy with intravenous immunoglobulins – a rational for monitoring immunoglobulin G levels.

Haematologica 106, 3249-3252 (2021).

De Poortere, J. et al.

Head-to-head comparison of cytokines storm-coagulopathy in septic shock and COVID-19.

Archives of Cardiovascular Diseases Supplements 13, 182 (2021).

Favresse, J. & Douxfils, J.

Evaluations of SARS-CoV-2 Serological Assay Performance Need Inclusion of Long-Term Samples.

J Clin Microbiol 59 (2021).

Pouplard, M. et al.

Évaluation et prise en charge du risque thrombotique chez les patients hospitalisés atteints de Covid-19.

Hémato-Onco 14, 38-43 (2020).

Foidart, J. M. et al.

Estetrol Is Safe and Well Tolerated during Treatment of Hospitalized Men and Women with Moderate COVID-19 in a Randomized, Double-Blind Study.

Journal of Clinical Medicine 12, 3928 (2023).

Douxfils, J. et al.

Efficient Maternal to Neonate Transfer of Neutralizing Antibodies after SARS-CoV-2 Vaccination with BNT162b2: A Case-Report and Discussion of the Literature.

Vaccines (Basel) 9 (2021).

Didembourg, M. et al.

Effect of tissue factor pathway inhibitor on thrombin generation assay.

International journal of laboratory hematology 44, e115-e119 (2022).

Favresse, J. et al.

Early antibody response in health-care professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2).

Clin Microbiol Infect 27, 1351 e1355-1351 e1357 (2021).

Favresse, J. et al.

Durability of humoral and cellular immunity six months after the BNT162b2 bivalent booster

(Authorea, Inc., 2023).

Gillot, C., Favresse, J., Maloteau, V., Dogne, J. M. & Douxfils, J.

Dynamics of Neutralizing Antibody Responses Following Natural SARS-CoV-2 Infection and Correlation with Commercial Serologic Tests. A Reappraisal and Indirect Comparison with Vaccinated Subjects.

Viruses 13, 2329 (2021).

Evrard, J.

Development of the FibWave, an improved clot waveform analysis for the assessment of hemostasis

PhD in Biomedical and Pharmaceutical Sciencesæ thesis, University of Namur, (2023).

Dechamps, M. et al.

Dexamethasone Modulates the Cytokine Response but Not COVID-19-Induced Coagulopathy in Critically Ill.

International Journal of Molecular Sciences 24, 7278 (2023).

Wauthier, L. et al.

D-dimer testing: A narrative review.

(2023).

Martini, A. et al.

Detection of Direct Oral Anticoagulants in Patient Urine Samples by Prototype and Commercial Test Strips for DOACs – A Systematic Review and Meta-analysis.

TH Open 5, e438-e448 (2021).

Wauthier, L. et al.

D-dimer Testing in Pulmonary Embolism with a Focus on Potential Pitfalls: A Narrative Review.

Diagnostics (Basel) 12, 2770 (2022).

Bayart, J. L. et al.

Confounding Factors Influencing the Kinetics and Magnitude of Serological Response Following Administration of BNT162b2.

Microorganisms 9, 1340 (2021).

Morimont, L., Gaspard, U., Foidart, J. M., Dogné, J.-M. & Douxfils,

Contraceptifs oraux combinés et thrombo-embolie veineuse: quels sont vriament les risques?

J. in Medi-Sphere Vol. 701 39-48 (2022).

Evrard, J. et al.

Comparison of analytical performances between clot waveform analysis and FibWave in edoxaban-treated patients and healthy controls.

Res Pract Thromb Haemost 6, e12804 (2022).

Favresse, J., Gillot, C. & Douxfils, J. Reply to Schulte-Pelkum, J.

Comment on “Favresse et al. Persistence of Anti-SARS-CoV-2 Antibodies Depends on the Analytical Kit: A Report for Up to 10 Months after Infection. Microorganisms 2021, 9, 556”.

Microorganisms 9, 1849 (2021).

Haguet, H. et al.

Clinical performance of the Panbio assay for the detection of SARS-CoV-2 IgM and IgG in COVID-19 patients.

J Med Virol 93, 3277-3281 (2021).

Favresse, J. et al.

Clinical performance of three fully automated anti-SARS-CoV-2 immunoassays targeting the nucleocapsid or spike proteins.

J Med Virol 93, 2262-2269 (2021).

Bayart, J. L. et al.

Clinical performance evaluation of the Fluorecare(R) SARS-CoV-2 & Influenza A/B & RSV rapid antigen combo test in symptomatic individuals.

J Clin Virol 161, 105419 (2023).

Favresse, J. et al.

Clinical Performance of the Elecsys Electrochemiluminescent Immunoassay for the Detection of SARS-CoV-2 Total Antibodies.

Clinical chemistry 66, 1104-1106 (2020).

Favresse, J., Douxfils, J., Henry, B., Lippi, G. & Plebani, M.

Clinical Chemistry and Laboratory Medicine celebrates 60 years – narrative review devoted to the contribution of the journal to the diagnosis of SARS-CoV-2.

Clinical chemistry and laboratory medicine : CCLM / FESCC 0, 811-821 (2022).

Favresse, J., Cabo, J. & Douxfils, J.

Cellular immunity against SARS-CoV-2 is predominantly boosted in vaccinated individuals with no history of infection.

J Infect (2023).

Favresse, J., Dogne, J. M. & Douxfils, J.

Assessment of the humoral response in Omicron breakthrough cases in healthcare workers who received the BNT162b2 booster.

Clinical chemistry and laboratory medicine : CCLM / FESCC 60, e153-e156 (2022).

Haguet, H.

Association of cardiovascular occlusive events with BCR-ABL tyrosine kinase therapy – Identification, understanding and prediction.

PhD in Biomedical and Pharmaceutical Sciences thesis, University of Namur, (2022).

Favresse, J. et al.

Antibody titres decline 3-month post-vaccination with BNT162b2.

Emerg Microbes Infect 10, 1495-1498 (2021).

Bayart, J. L. et al.

Analytical Sensitivity of Six SARS-CoV-2 Rapid Antigen Tests for Omicron versus Delta Variant.

Viruses 14 (2022).

Tre-Hardy, M. et al.

Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies.

J Med Virol 93, 803-811 (2021).

Gillot, C. et al.

An Original ELISA-Based Multiplex Method for the Simultaneous Detection of 5 SARS-CoV-2 IgG Antibodies Directed against Different Antigens.

J Clin Med 9 (2020).

Favresse, J. et al.

An original multiplex method to assess five different SARS-CoV-2 antibodies.

Clinical chemistry and laboratory medicine : CCLM / FESCC 59, 971-978 (2021).